Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma

Mariana Lobato; João Gaspar-Marques; Pedro Carreiro-Martins; Paula Leiria-Pinto

doi:10.1016/j.anai.2022.01.001

Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma

Mariana Lobato, João Gaspar-Marques, Pedro Carreiro-Martins, Paula Leiria-Pinto

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	464-466
Journal	Annals of Allergy, Asthma and Immunology
Volume	128
Issue number	4
Early online date	8 Jan 2022
DOIs	https://doi.org/10.1016/j.anai.2022.01.001
Publication status	Published - Apr 2022

Access to Document

10.1016/j.anai.2022.01.001

Cite this

@article{ad38db51cdb840f1bb6abe0086089fb4,

title = "Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma",

author = "Mariana Lobato and Jo{\~a}o Gaspar-Marques and Pedro Carreiro-Martins and Paula Leiria-Pinto",

note = "Funding Information: Disclosures: Dr Gaspar-Marques reports receiving research grants from AstraZeneca and honorarium as speaker, consultant from AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, and Teva. Dr Carreiro-Martins reports receiving research grants from AstraZeneca and honorarium as speaker, consultant from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi. The remaining authors have no conflicts of interest regarding this article. ",

year = "2022",

month = apr,

doi = "10.1016/j.anai.2022.01.001",

language = "English",

volume = "128",

pages = "464--466",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "4",

}

TY - JOUR

T1 - Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma

AU - Lobato, Mariana

AU - Gaspar-Marques, João

AU - Carreiro-Martins, Pedro

AU - Leiria-Pinto, Paula

N1 - Funding Information: Disclosures: Dr Gaspar-Marques reports receiving research grants from AstraZeneca and honorarium as speaker, consultant from AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, and Teva. Dr Carreiro-Martins reports receiving research grants from AstraZeneca and honorarium as speaker, consultant from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi. The remaining authors have no conflicts of interest regarding this article.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124514704&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2022.01.001

DO - 10.1016/j.anai.2022.01.001

M3 - Article

C2 - 35007743

AN - SCOPUS:85124514704

SN - 1081-1206

VL - 128

SP - 464

EP - 466

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 4

ER -

Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma

Access to Document

Other files and links

Cite this